Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,964,000
New position
Shares Held
200,000
first reported quarter
Ownership
0.342%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026SOROS FUND MANAGEMENT LLC holds $200,396,084 across 6 Biotechnology names. ACLX ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
5,753,186 | $83,191,069 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,056,000 | $42,482,880 | |
| 3 | DAWN |
Day One Biopharmaceuticals, Inc.
|
1,539,100 | $32,998,304 | |
| 4 | ACLX |
Arcellx, Inc.
This page
|
200,000 | $22,964,000 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
321,905 | $16,970,831 | |
| 6 | AKTS |
Aktis Oncology, Inc.
|
100,000 | $1,789,000 |
All Filings in ACLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,964,000 | 200,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||